Safety, Tolerability and Pharmacodynamics of BPL-003 for depression
This study is recruiting in the United Kingdom. It is testing Safety, Tolerability and Pharmacodynamics of BPL-003 for depression.
Multiple locations, including Liverpool
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in the United Kingdom. It is testing Safety, Tolerability and Pharmacodynamics of BPL-003 for depression.
Multiple locations, including LiverpoolThis study is recruiting. It focuses on depression and currently lists participation information in France.
In Boulogne-BillancourtThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In DetroitThis study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In PhiladelphiaThis study is recruiting in the United Kingdom. It focuses on depression.
In United KingdomThis study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on depression and currently lists participation information in Switzerland.
In BaselThis study is recruiting. It focuses on depression and currently lists participation information in the Netherlands.
In NetherlandsThis study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.
In United KingdomHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.